Virtual Rehabilitation for Cancer Survivors
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants can be on certain ongoing therapies like trastuzumab, immunotherapy, and others, so it seems likely you can continue your current medications.
What data supports the effectiveness of the treatment CaRE@Home intervention for cancer survivors?
Research suggests that telehealth-based cancer rehabilitation, like CaRE@Home, can effectively improve physical and mental health in cancer survivors, similar to traditional in-clinic programs. Studies show that hybrid and telehealth delivery modes can provide comparable benefits in health outcomes and patient satisfaction, making them a promising option for increasing access to rehabilitation services.12345
Is virtual rehabilitation safe for cancer survivors?
How is the CaRE@Home treatment different from other cancer rehabilitation treatments?
CaRE@Home is unique because it offers a virtual, online rehabilitation and exercise program for cancer survivors, making it accessible to those who cannot attend facility-based programs due to distance, cost, or other commitments. This telehealth approach allows for scalable and remote interventions, potentially reaching a larger population of cancer survivors.12489
What is the purpose of this trial?
Pragmatic hybrid type 1 effectiveness-implementation (E-I) trial of a virtual cancer rehabilitation program: The study team will conduct a multi-center hybrid type I effectiveness-implementation study to examine the clinical effectiveness and implementation potential of an 8-week multidimensional virtual cancer rehabilitation intervention (CaRE@Home) for cancer survivors with identified cancer-related impairments on level of overall disability (primary outcome) and patient reported physical and social functioning, anxiety, work status, quality of life, and physiologic changes (secondary outcomes). The study team will conduct a multi-centre pragmatic randomized controlled trial (RCT) (Vancouver, Toronto, Saint John and St. John's) to evaluate effectiveness and using the CIFR, the study team will identify potential factors that may affect successful implementation and integration of CaRE@Home in different cancer settings.
Research Team
Jennifer Jones, PhD
Principal Investigator
UHN Princess Margaret Cancer Centre
Eligibility Criteria
This trial is for cancer survivors aged 18+ who've finished primary treatment within the last 2 years. It's open to those with breast, colorectal, head and neck cancers or lymphoma if they're responding well to ongoing therapies like immunotherapy. Participants need good enough English for the intervention, internet access, and a WHO-DAS score over 5 indicating a need for rehab.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week virtual cancer rehabilitation program (CaRE@Home) with weekly e-modules, exercise prescriptions, and counseling
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 3 and 6 months post-intervention
Maintenance Assessment
Additional follow-up at 6 months post-intervention to assess maintenance of treatment gains
Treatment Details
Interventions
- CaRE@Home intervention
CaRE@Home intervention is already approved in Canada for the following indications:
- Rehabilitation for cancer survivors with identified cancer-related impairments
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor